NCT04983953

Brief Summary

cHS is a software that has been pre-learned based on a intracranial haemorrhage diagnosis model using brain CT images, and clinical decision support system for diagnosing intracranial haemorrhage by automatically analyzing brain CT images by assisting the medical team. The specific aims of this study are to evaluate efficacy of cHS for intracranial haemorrhage compared to the sensitivity and specificity levels of predicate device which is currently approved to triage intracranial haemorrhage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
236

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 23, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2021

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

July 29, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 30, 2021

Completed
Last Updated

January 14, 2022

Status Verified

January 1, 2022

Enrollment Period

1 month

First QC Date

July 29, 2021

Last Update Submit

January 12, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sensitivity and specificity of cHS

    Sensitivity and specificity of cHS in diagnosis of intracranial haemorrhage based on golden standards

    Within 4 weeks after collecting data

Study Arms (2)

Abnormal

A patient diagnosed with intracranial haemorrhage after a brain CT scan

Device: cHS

Normal

A normal person or a patient not diagnosed with intracranial haemorrhage after a brain CT scan

Device: cHS

Interventions

cHSDEVICE

Clinical decision support system for diagnosing intracranial haemorrhage

AbnormalNormal

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

(1) Adults over 19 years old (2) Brain CT images acquired (3) who confirmed with intracranial haemorrhage(abnormal cohort) or not intracranial haemorrhage or normal(normal cohort)

You may qualify if:

  • Adults over 19 years old
  • Brain CT acquired
  • Abnormal cohort: A patient diagnosed with intracranial haemorrhage after a brain CT scan
  • Normal cohort: A normal person or a patient not diagnosed with intracranial haemorrhage after a brain CT scan

You may not qualify if:

  • Patients with brain tumor or cerebral toxoplasmosis
  • Patients with brain abscess or brain calcification
  • Poor or incomplete brain CT image quality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gachon University Gil Medical Center

Incheon, Namdong-gu, 21565, South Korea

Location

MeSH Terms

Conditions

Intracranial Hemorrhages

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2021

First Posted

July 30, 2021

Study Start

June 23, 2021

Primary Completion

July 28, 2021

Study Completion

July 28, 2021

Last Updated

January 14, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations